This inventor holds 3 USPTO granted patents. Top assignees: Wisconsin Alumni Research Foundation, The Ohio State University. Active years: 2009-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4,238 
1 out of 1,584 
Years Active: 2009-2016
Title: Galal A Alshafie: Innovator in Cancer Treatment
Introduction
Galal A Alshafie is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 3 patents, Alshafie's work focuses on developing compounds that can inhibit neoplastic cell growth.
Latest Patents
Alshafie's latest patents include the "C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and methods of using the same to inhibit neoplastic cell growth." These compounds are described along with pharmaceutical compositions that contain them. The methods outlined in his patents aim to prevent and treat cancer in mammals, including humans.
Career Highlights
Throughout his career, Alshafie has worked with reputable organizations such as the Wisconsin Alumni Research Foundation and The Ohio State University. His research has been pivotal in advancing the understanding and treatment of cancer.
Collaborations
Alshafie has collaborated with esteemed colleagues, including Margaret Clagett-Dame and Robert W Curley, Jr. These partnerships have further enriched his research and contributed to the development of his patented inventions.
Conclusion
Galal A Alshafie's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the field of medicine. His contributions continue to pave the way for advancements in therapeutic options for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile